Bemdaneprocel is a cell therapy composed of human embryonic stem cell-derived midbrain dopaminergic neuron progenitor cellsThe post AAN 2026: BlueRock reports positive safety data for bemdaneprocel in Parkinson’s appeared first on Clinical Trials Arena.
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.